Skip to main content
NewslettersWatchlist

Idexx Laboratories(IDXX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low479.88
Day High494.82
Open:494.82
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Newswire.ca
IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect
Barchart
Stocks Finish Lower as Rate Cut Hopes Recede on Hawkish Fed
Barchart
Stocks Fall as Bond Yields Jump on Hawkish Fed Comments and Strong ISM Services Report
Newswire.ca
IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
Newswire.ca
IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
Motley Fool
3 Top Healthcare Stocks to Buy for August
PR Newswire
IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates
Barchart
Stocks End Holiday-Shortened Session Slightly Higher
Barchart
Stocks Slightly Lower as U.S. Manufacturing Activity Unexpectedly Contracts
MarketBeat
Bullish or Bearish? Vetting Animal Health Care Stocks
PR Newswire
IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio
Motley Fool
3 Nasdaq Stocks That Have Generated 10x Returns in 10 Years
The Globe and Mail
Expanding array of services for pets offers investors chance to get in on sector’s growth
Motley Fool
3 Best Stocks to Buy in May and Hold Forever
Business Wire
IDEXX Laboratories Announces First Quarter Results
Motley Fool
Why These 2 Vet Med Stocks Are Surging
Business Wire
IDEXX Laboratories to Release 2023 First Quarter Financial Results
PR Newswire
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
PR Newswire
Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity
MarketBeat
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Motley Fool
2 Top Healthcare Stocks to Buy Right Now
Motley Fool
2 Top Stocks I'm Buying Hand Over Fist in February
The Globe and Mail
15 top-ranked Nasdaq-listed stocks with bullish upside momentum
Barchart
Stocks Lower on the Outlook for Hawkish Fed
PR Newswire
IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results
PR Newswire
IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results
Barchart
Stock Climb on U.S. Inflation Optimism
Barchart
Stocks Little Changed as Powell Refrains from Commenting on Monetary Policy
MarketBeat
GE HealthCare Technologies Soars As GE Legacy Business Plummets
Motley Fool
3 Surefire Stocks I'm Buying for My Daughter's Portfolio in 2023
PR Newswire
IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
The Globe and Mail
IDEXX Laboratories: Top 25 Undervalued Nasdaq Composite Index Stocks (IDXX)

Profile

IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.